Cargando…
Meningoradiculitis post-COVID-19 mRNA vaccination: A case report
We present a rare case of meningoradiculitis occurring after mRNA COVID-19 vaccination. This patient, with a history of inflammatory arthritis following rubella vaccination, presented to the emergency department 4 days after her vaccination with both central and radicular nervous system symptoms. Sy...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Authors. Published by Elsevier Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8923012/ http://dx.doi.org/10.1016/j.clicom.2022.03.004 |
_version_ | 1784669608306802688 |
---|---|
author | Landry, Alexandre Crapoulet, Stéphanie Boudreau, Luc H. Bourque, Christine Weston, Lyle Pilote, Nicholas Desnoyers, Guillaume Chamard-Witkowski, Ludivine |
author_facet | Landry, Alexandre Crapoulet, Stéphanie Boudreau, Luc H. Bourque, Christine Weston, Lyle Pilote, Nicholas Desnoyers, Guillaume Chamard-Witkowski, Ludivine |
author_sort | Landry, Alexandre |
collection | PubMed |
description | We present a rare case of meningoradiculitis occurring after mRNA COVID-19 vaccination. This patient, with a history of inflammatory arthritis following rubella vaccination, presented to the emergency department 4 days after her vaccination with both central and radicular nervous system symptoms. Symptoms included pain, sensory and motor deficits in L5 roots distribution, along with signs of central irritation, such as headache, difficulty concentrating and a Babinski sign. MRI showed bilateral L5 nerve roots enhancement. Lumbar puncture showed elevated protein and IgG, and relevant serologies excluded common causes. Prednisone and physical therapy helped the patient to achieve near complete recovery nine weeks after presentation. We concluded that this patient presented meningoradiculitis probably secondary to her vaccination in a context of possible overactive immune system. While such presentations might be rare, and do not constitute a general reason to abstain from vaccination, they must be well recognized and treated. |
format | Online Article Text |
id | pubmed-8923012 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | The Authors. Published by Elsevier Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-89230122022-03-15 Meningoradiculitis post-COVID-19 mRNA vaccination: A case report Landry, Alexandre Crapoulet, Stéphanie Boudreau, Luc H. Bourque, Christine Weston, Lyle Pilote, Nicholas Desnoyers, Guillaume Chamard-Witkowski, Ludivine Clinical Immunology Communications Case Report We present a rare case of meningoradiculitis occurring after mRNA COVID-19 vaccination. This patient, with a history of inflammatory arthritis following rubella vaccination, presented to the emergency department 4 days after her vaccination with both central and radicular nervous system symptoms. Symptoms included pain, sensory and motor deficits in L5 roots distribution, along with signs of central irritation, such as headache, difficulty concentrating and a Babinski sign. MRI showed bilateral L5 nerve roots enhancement. Lumbar puncture showed elevated protein and IgG, and relevant serologies excluded common causes. Prednisone and physical therapy helped the patient to achieve near complete recovery nine weeks after presentation. We concluded that this patient presented meningoradiculitis probably secondary to her vaccination in a context of possible overactive immune system. While such presentations might be rare, and do not constitute a general reason to abstain from vaccination, they must be well recognized and treated. The Authors. Published by Elsevier Inc. 2022-12 2022-03-15 /pmc/articles/PMC8923012/ http://dx.doi.org/10.1016/j.clicom.2022.03.004 Text en © 2022 The Authors. Published by Elsevier Inc. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Case Report Landry, Alexandre Crapoulet, Stéphanie Boudreau, Luc H. Bourque, Christine Weston, Lyle Pilote, Nicholas Desnoyers, Guillaume Chamard-Witkowski, Ludivine Meningoradiculitis post-COVID-19 mRNA vaccination: A case report |
title | Meningoradiculitis post-COVID-19 mRNA vaccination: A case report |
title_full | Meningoradiculitis post-COVID-19 mRNA vaccination: A case report |
title_fullStr | Meningoradiculitis post-COVID-19 mRNA vaccination: A case report |
title_full_unstemmed | Meningoradiculitis post-COVID-19 mRNA vaccination: A case report |
title_short | Meningoradiculitis post-COVID-19 mRNA vaccination: A case report |
title_sort | meningoradiculitis post-covid-19 mrna vaccination: a case report |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8923012/ http://dx.doi.org/10.1016/j.clicom.2022.03.004 |
work_keys_str_mv | AT landryalexandre meningoradiculitispostcovid19mrnavaccinationacasereport AT crapouletstephanie meningoradiculitispostcovid19mrnavaccinationacasereport AT boudreauluch meningoradiculitispostcovid19mrnavaccinationacasereport AT bourquechristine meningoradiculitispostcovid19mrnavaccinationacasereport AT westonlyle meningoradiculitispostcovid19mrnavaccinationacasereport AT pilotenicholas meningoradiculitispostcovid19mrnavaccinationacasereport AT desnoyersguillaume meningoradiculitispostcovid19mrnavaccinationacasereport AT chamardwitkowskiludivine meningoradiculitispostcovid19mrnavaccinationacasereport |